◀ Back to MAPK3

MAPK3 — UTS2

Text-mined interactions from Literome

Chen et al., Zhonghua Yi Xue Za Zhi 2000 : The effect of Urotensin II-stimulated airway smooth muscle cells DNA synthesis is mediated by Ca2+, PKC, MAPK and CaN signal transduction pathway
Watanabe et al., Circulation 2001 : The synergistic interaction between UII and moxLDL was partially inhibited by anti-Gq/11alpha antibody, the epidermal growth factor receptor tyrosine kinase inhibitor erbstatin A ( 10 micromol/L ), and the intracellular free radical scavenger N-acetylcysteine ( 400 micromol/L ) and was completely inhibited by the c-Src tyrosine kinase inhibitor radicicol ( 10 micromol/L ), the protein kinase C ( PKC ) inhibitor Ro31-8220 ( 0.1 micromol/L ), and the mitogen activated protein kinase ( MAPK ) kinase inhibitor PD098059 ( 10 micromol/L )
Chen et al., Chin Med J (Engl) 2004 : In primary cultures of rat ASMCs, activities of protein kinase C ( PKC ), mitogen activated protein kinase ( MAPK ) and calcineurin ( CaN ) induced by UII were measured ... UII 10 ( -7 ) mol/L stimulated ASMC PKC and MAPK activities by 44 % and 24 % ( P < 0.01 ), respectively, after incubating for 20 minutes ... UII increases cytosolic free calcium concentration and activates PKC, MAPK and CaN
Onan et al., Mol Endocrinol 2004 (Cardiomegaly) : Urotensin II potently activated the MAPKs, ERK1/2 and p38, and blocking these kinases with PD098059 and SB230580, respectively, significantly inhibited urotensin II-mediated hypertrophy
Dai et al., Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006 : [ Effect of urotensin II on proliferative potential and phosphorylation of extracellular signal regulated kinase 1/2 of adventitial fibroblasts from spontaneously hypertensive rat ]